## Mechanism of Action of Macrolides **Key Point:** Macrolides bind irreversibly to the bacterial 50S ribosomal subunit, inhibiting peptide bond formation and causing premature termination of protein synthesis. ### Ribosomal Binding Site Macrolides (erythromycin, azithromycin, clarithromycin) specifically target the 50S subunit of the bacterial ribosome, which is structurally distinct from the eukaryotic 80S ribosome. This selectivity provides the basis for their antimicrobial activity with relatively low toxicity to host cells. ### Mechanism Details 1. Binding occurs at the peptidyl transferase center of the 50S subunit 2. Prevents translocation of peptides and mRNA 3. Results in bacteriostatic effect (halts growth rather than killing) 4. Effective against gram-positive cocci, some gram-negative organisms, and atypical pathogens **High-Yield:** The 50S inhibition distinguishes macrolides from aminoglycosides (30S inhibitors) and fluoroquinolones (DNA gyrase inhibitors). ### Comparison with Other Protein Synthesis Inhibitors | Drug Class | Ribosomal Target | Bacteriostatic/Cidal | |---|---|---| | Macrolides | 50S | Bacteriostatic | | Aminoglycosides | 30S | Bactericidal | | Tetracyclines | 30S | Bacteriostatic | | Chloramphenicol | 50S | Bacteriostatic | | Linezolid | 50S | Variable | **Clinical Pearl:** Because macrolides are bacteriostatic, they rely on host immune function for complete eradication of infection, making them less suitable for immunocompromised patients in severe infections.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.